1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. The scarcity of organs donors.
4.1.2. Growing number of disabilities and organ failures
4.1.3. Technological advancements
4.2 Restraints & Challenges
4.2.1. High-cost procedures
4.2.2. Increasing device malfunctions.
4.3 Opportunities
4.3.1 Demand for artificial organs and bionics in the health sector.
5. North America Artificial Organs and Bionics Market – By Product
5.1. Artificial organs
5.2. Bionics
6. North America Artificial Organs and Bionics Market – By Technology
6.1. Mechanical bionics
6.2. Electronic bionics
7. North America Artificial Organs and Bionics Market – By Application
7.1 Healthcare
7.2 Defense
8. North America Artificial Organs and Bionics Market - By Geography
8.1 Introduction
8.2 North America
8.2.1. The U.S.
8.2.2. Canada
8.2.3. Mexico
9. North America Artificial Organs and Bionics Market - Company Profiles
9.1. Baxter International Inc.
9.2. Boston Scientific Corporation.
9.3. Berlin Heart GmbH.
9.4. Cochlear Limited.
9.5. Cyberonics Inc.
9.6. Edward Lifesciences Corporation
9.7. Medtronic PLC
9.8. Gambro AB.
9.9. LifeNet health Inc.
9.10. Otto Bock Healthcare GmbH.
9.11. Abiomed Inc.
9.12. F Hoffman La Roche Ltd
9.13. iWalk Inc.
10. North America Artificial Organs and Bionics Market - Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
